PHARMACOKINETICS AND METABOLISM OF THE NEW THROMBOXANE A(2) RECEPTOR ANTAGONIST RAMATROBAN IN ANIMALS - 1ST COMMUNICATION - ABSORPTION, CONCENTRATIONS IN PLASMA, METABOLISM, AND EXCRETION AFTER SINGLE ADMINISTRATION TO RATS AND DOGS
M. Boberg et al., PHARMACOKINETICS AND METABOLISM OF THE NEW THROMBOXANE A(2) RECEPTOR ANTAGONIST RAMATROBAN IN ANIMALS - 1ST COMMUNICATION - ABSORPTION, CONCENTRATIONS IN PLASMA, METABOLISM, AND EXCRETION AFTER SINGLE ADMINISTRATION TO RATS AND DOGS, Arzneimittel-Forschung, 47(8), 1997, pp. 928-938
The absorption, concentrations in plasma, metabolism and excretion of
ramatroban lfonamido)-1,2,3,4-tetrahydro-9-carbazolepropanoic acid, CA
S 116649-85-5, BAY u 3405) have been studied following a single intrav
enous, oral, or intraduodenal administration of C-14-labeled or non-la
beled compound to rats and dogs (dose range: 1-10 mg.kg(-1)). After in
traduodenal administration of [C-14]ramatroban, enteral absorption of
radioactivity was rapid and almost complete both in bile duct-cannulat
ed male rats (83%) and female dogs (95%). The oral bioavailability of
ramatroban was complete in the dog but amounted to about 50% in the ra
t due to presystemic elimination. A marked food effect on the rate but
not on the extent of absorption was observed in rats. The elimination
of the parent compound from plasma occurred rapidly with total cleara
nce of 1.21.h(-1).kg(-1) in male rats and 0.71.h(-1).kg(-1) in dogs. A
fter oral administration to male rats AUC increased dose-proportionall
y between 1 and 10 mg.kg(-1), whereas in C-max an over-proportional in
crease was observed. Excretion of total radioactivity was fast and occ
urred predominantly via the biliary/fecal route in both species. The r
esidues were low, 144 h after dosing less than 0.2% of the radioactivi
ty remained in the body of rats. A considerable sex difference was fou
nd in rats following oral administration of ramatroban. In females a 3
-fold higher AUC and a 1.7-fold longer half-life of unchanged compound
, as well as 3-fold higher renal excretion of total radioactivity was
observed. A marked species difference exists in the metabolism of rama
troban. In dogs the drug was almost exclusively metabolized via conjug
ation with glucuronic acid, whereas in rats oxidative phase I metaboli
sm and glucuronidation were equally important. As a consequence entero
hepatic circulation was much more pronounced in dogs (77%) than in rat
s (17% of the initial dose).